TrialClinical and experimental immunology2020

Combination of pegylated interferon-alpha and nucleos(t)ide analogue treatment enhances the activity of natural killer cells in nucleos(t)ide analogue experienced chronic hepatitis B patients.

X Pang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.